Argenta

Advanced Molecular Technologies Pty Ltd (AMT) is a contract research organisation (CRO) established in 2005, specialising in medicinal chemistry and custom organic synthesis. The provided services involve the synthesis of target molecules, the manufacturing (larger-scale) of chemical materials, analytical chemistry, chemical method development and optimisation, drug discovery and synthetic organic research.

AMT is also a manufacturer and supplier of chemicals in Victoria, Australia, distributing specialty products to partners, institutions and companies worldwide.

AMT has extensive experience in organoboron, organosilicon, PEG-linkers and fluorophore technology, with many of these discrete molecules available for purchase on their website. More recently, AMT is spinning-out its own initiatives through novel technology developed within the pharmaceutical and veterinary industries.

Equipped with a 400 MHz NMR machine, HPLC, GC, FT-IR and several other analytical pieces of equipment, AMT also readily provides analytical services to the chemical industry.

WE LIVE FOR HEALTHIER PEOPLE, THE WORLD OVER, EVERYDAY
We believe in eating your way to health, and that health can, and should taste great. We believe that health doesn’t have to be a chore, it doesn’t have to be a bad tasting experience and it isn’t a pill that you pop and you’re done. We believe in using the best possible ingredients and, wherever possible, that’s Australian organic. We believe in helping people make healthier choices by offering great tasting products to support their wellbeing. We believe in Australia. We are proudly 100% Australian owned.

WHOLE BODY HEALTH SINCE 1978
Established in Melbourne during the 70s, Melrose is a homegrown, family-owned business with deep roots in Australia’s health food industry and a long history of market leadership and product innovation. Over the years, Melrose has grown to be one of Australia’s leading and most trusted health food brands. Today, The Melrose Group has over 100 employees, two manufacturing sites in Melbourne, and an ever-growing range of products to support whole body health.

Datapharm is Australia’s original independent full-service Contract Research Organisation (CRO), est. 1987, providing clinical trial management, design, site set-up, monitoring, statistical services, data management (including eCRFs), medical writing, pharmacovigilance and auditing.
Datapharm has earned an enviable reputation for quality, following involvement in hundreds of clinical trials in over 35 therapeutic areas, Phases I (including first-in-human) to IV, for Big Pharma, Biotech, Medical Device companies and Non-profit organisations.
Datapharm works to ICH GCP and international regulatory authority standards with an overlay of excellent project management to achieve project milestones.
Datapharm offers services internationally through the global CRO consortium DAI-SYS.

Our four clinical research sites are capable of performing studies from small scale Phase 1b trials to large scale, longer term Phase 3 studies. Since 2001 we have been trusted to perform over 120 clinical studies on behalf of worldwide pharmaceutical companies, contract research organisations and individual researchers. As a result we have accumulated a large volunteer database for our clinical trials.

We are the intellectual property (IP) firm of choice for global companies seeking the best IP advice and solutions. Acting for a large number of innovative Australasian companies and over a third of global Fortune 500 companies with IP interests in the region, we are the IP firm of choice for providing the best IP solutions. To find out more, visit our website at www.ajpark.com. You can also follow us on Twitter: http://twitter.com/AJParkIP.

AJ Park is a member of the IPH Limited group. For more information about members of the IPH group, please visit www.iphltd.com.au/about-iph/.